home / stock / vm:cc / vm:cc news

VM:CC News and Press, Voyageur Pharmaceuticals Ltd. From 07/13/23

Stock Information
Company Name: Voyageur Pharmaceuticals Ltd.
Stock Symbol: VM:CC
Market: TSXVC
Website: voyageurpharmaceuticals.ca
Menu
VM:CC VM:CC Quote VM:CC Short VM:CC News VM:CC Articles VM:CC Message Board
Get VM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
VM:CC - Voyageur Pharmaceuticals Ltd. Announces DSU Grants

(TheNewswire) Calgary, Alberta - TheNewswire - July 13, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the " Company " or " Voyageur ") announces that on July 10, 2023, it issued 383,360 Deferred Share Units ("DSUs") to directors of the ...
VM:CC - Voyageur Pharmaceuticals Publishes White Paper, SmoothX: A Promising New Positive Oral Contrast Agent That Enhances Patient Satisfaction and Diagnostic Excellence in CT Imaging

(TheNewswire) Calgary, Canada – TheNewswire - June 12, 2023 - Voyageur Pharmaceuticals Ltd . ( TSXV:VM ) ( USA : VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, is pleased to announce the release of the whi...

VM:CC - Voyageur Pharmaceuticals shares successful environmental assessment for minerals subsidiary

(NewsDirect) Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studios to discuss the successful completion of environmental and geotechnical field work assessment at its Frances Creek project site through its 100% owned subsidiary Voyageur Industrial Mi...

VM:CC - Voyageur Pharmaceuticals with a "big market to go for"

--News Direct-- Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in transforming raw materials into pharmaceutical-grade contrast agents that can be...
VM:CC - Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work at Frances Creek Project Site For Notice of Work & Quarry Permitting

(TheNewswire) Calgary, AB - TheNewswire - May 31, 2023 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC :VYYRF) (" Voyageur " or the " Corporation ") announces the successful completion of environmental and geotechnical fi...

VM:CC - The Power Play by The Market Herald Releases New Interviews with Solar Alliance, Cleantek Industries, Voyageur Pharmaceuticals and Homerun Resources Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / May 24, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Solar Alliance, Cleantek Industries, Voyageur Pharmaceuticals and Homerun Resources discussing their latest news. The Power Play by The Market Herald provides investo...

VM:CC - Voyageur Pharmaceuticals partners with Rain Cage to develop nanocarbon-based radiology drugs

--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis join's Proactive's Natalie Stoberman to share a significant licensing agreement with Rain Cage Carbon to develop nanocarbon-based contrast drugs for medical imaging. Willis says the partnership aims to develop new contrast agen...
VM:CC - Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs

(TheNewswire) Click Image To View Full Size Calgary, Canada – TheNewswire - May 24, 2023 - Voyageur Pharmaceuticals Ltd . ( TSXV:VM ) ( OTC :VYYRF) ("Voyageur" or the "Corporation"), announces it has entered into a groundbreaking  ...

VM:CC - Voyageur Pharmaceuticals Ltd. Files Interim Financial Statements and Grants Deferred Share Units

(TheNewswire) Calgary, AB - TheNewswire - April 28, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the " Company " or " Voyageur ") announces that it has filed its interim financial statements and management's discussion and anal...

VM:CC - Voyageur Pharmaceuticals' SmoothX abdominal diagnostic drink gets high praise in comparative study

--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joins Proactive's Natalie Stoberman to share the latest results from its SmoothX comparative studies. Willis says results of the double-blind testing showed that SmoothX was favoured on drinkability and taste by 75% of patients com...
Previous 10 Next 10